期刊文献+

银杏达莫注射液对急性心肌梗死患者直接经皮冠状动脉成形术后心肌灌注和临床预后的影响 被引量:5

Effect of Ginkgo dipyridamole injection on myocardial perfusion and prognosis of patients with acute myocardial infarction after primary percutaneous coronary intervention
下载PDF
导出
摘要 目的探讨银杏达莫注射液对急性心肌梗死(AMI)患者行直接经皮冠状动脉成形术(PCI)后心肌灌注和临床预后的影响。方法 74例行直接PCI的AMI患者随机分为银杏达莫联用替罗非班组(研究组,37例)与单用替罗非班组(对照组,37例),分析术后心肌灌注情况,住院期间和随访6个月时的心血管事件发生情况。结果两组间PCI术后心肌梗死溶栓试验(TIMI)血流分级的差异无统计学意义(P>0.05)。研究组术后校正的TIMI计帧法(CTFC)为(24.4±6.3)帧,显著少于对照组的(28.1±15.4)帧(P=0.032)。研究组术后ST回落<50%有3例(8.1%),显著低于对照组的8例(21.6%,P<0.05)。研究组住院期间2例死亡,与对照组(6例)的差异无统计学意义(P=0.10)。两组随访6个月时的心血管事件发生率的差异均无统计学意义(P值均>0.05)。结论与单用替非罗斑比较,银杏达莫联合替非罗斑能有效地改善心肌血流灌注,在临床上有一定的应用前景,但需要更大规模的临床试验来证实其临床效果。 Objective To discuss of the effect of Ginkgo dipyridamole injection on myocardial perfusion and clinical prognosis of patients with acute myocardial infarction(AMI)after primary percutaneous coronary intervention(PCI).Methods Seventy-four AMI patients treated by PCI were randomized into Ginkgo dipyridolum Tirofiban group(n=37)and Tirofiban group(n=37).The post-PCI myocardial perfusion was analyzed and the cardiac events were observed during hospitalization and within 6 months after discharge.Results The thrombolysis in myocardial infarction(TIMI)flow grades were not significantly different between the two groups after PCI(P0.05).The corrected TIMI frame count(CTFC)in Ginkgo dipyridamole + Tirofiban group was significantly lower than that in Tirofiban group(24.4±6.3 vs.28.1±15.4,P=0.032).Three(8.1%)patients in Ginkgo dipyridamole + Tirofiban group had their postoperative ST dropped by less than 50%,which was significantly less than that in the Tirofiban group(8[21.6%],P0.05).There were 2 deaths in Ginkgo dipyridamole + Tirofiban group and 6 deaths in Tirofiban group during hospitalization(P=0.10).The incidences of cardiac events were not significantly different between the two groups during the 6 months of follow-up(P0.05).Conclusions Compared to Tirofiban alone,Ginkgo dipyridolum combined with Tirofiban can effectively improve myocardial perfusion,showing a clinical application potential,but the exact effect needs to be verified by more large-scale clinical trials.
出处 《上海医学》 CAS CSCD 北大核心 2010年第10期930-933,共4页 Shanghai Medical Journal
基金 上海市医学重点专科心血管内科资助(05-Ⅱ026) 上海中医药大学附属普陀医院院级课题(2007Z047A)
关键词 银杏达莫 直接经皮冠状动脉成形术 急性心肌梗死 心肌灌注 Ginkgo dipyridolum Primary percutaneous coronary intervention Acute myocardial infarction Myocardial perfusion
  • 相关文献

参考文献18

  • 1Keeley E C,Boura J A,Grines C L.Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction:a quantitative review of 23 randomised trials.Lancet,2003,361:13-20. 被引量:1
  • 2Morishima I,Sone T,Okumura K,et al.Angiographic no reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction.J Am Coll Cardiol,2000,36:1202-1209. 被引量:1
  • 3Kubica J,Koziński M.No-reflow phenomenon:Achilles' heel of primary coronary angioplasty in acute myocardial infarction.Cardiol J,2008,16:1-3. 被引量:1
  • 4Henriques J P,Zijlstra F,Ottervanger J P,et al.Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction.Eur Heart J.2002,23:1112-1117. 被引量:1
  • 5Ito H,Maruyama A,Iwakura K,et al.Clinical implications of the 'no reflow' phenomenon.A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction.Circulation,1996,93:223-228,. 被引量:1
  • 6Zhao J L,Yang Y J,You S J,et al.Pretreatment with fosinopril or valsartan reduces myocardial no-reflow after acute myocardial infarction and reperfusion.Coron Artery Dis,2006,17:463-469. 被引量:1
  • 7Iwakura K,Ito H,Kawano S,et al.Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction.Eur Heart J,2006,27:534-539. 被引量:1
  • 8Yang Y J,Zhao J L,You S J,et al.Different effects of tirofiban and aspirin plus clopidogrel on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion.Heart,2006,92:1131-1137. 被引量:1
  • 9杨伟,金惠根,刘宗军,汪蔚青,施佳,汪志华,沈峻,于宏梅,方平.冠状动脉内注射国产替罗非班治疗冠状动脉介入治疗后无复流成功一例[J].上海医学,2006,29(11):771-771. 被引量:1
  • 10郑昭芬,蒲晓群,杨天崙,李传昶,彭道地,余再新,莫龙,陈晓彬.地尔硫对急性心肌梗死患者急诊冠状动脉介入治疗中无再流的作用[J].中南大学学报(医学版),2006,31(6):917-920. 被引量:5

二级参考文献28

共引文献26

同被引文献87

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部